Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Angeline Poh Gek Chua"'
Autor:
Sze Ling Chan, Angeline Poh Gek Chua, Folefac Aminkeng, Cynthia Bin Eng Chee, Shengnan Jin, Marie Loh, Suay Hong Gan, Yee Tang Wang, Liam R Brunham
Publikováno v:
PLoS ONE, Vol 12, Iss 10, p e0186200 (2017)
Isoniazid (INH) is part of the first-line-therapy for tuberculosis (TB) but can cause drug-induced liver injury (DILI). Several candidate single nucleotide polymorphisms (SNPs) have been previously identified but the clinical utility of these SNPs in
Externí odkaz:
https://doaj.org/article/27353b8661e9417d92a67959f055d015
Autor:
Leo Kang Yang Lim, Angeline Poh-Gek Chua, S. Tan, Suay-Hong Gan, Li-Hwei Sng, Cynthia B.E. Chee, Yee-Tang Wang
Publikováno v:
D26. CLINICAL AND EPIDEMIOLOGICAL DEVELOPMENTS IN TB.
Publikováno v:
Tuberculosis.
Autor:
Angeline Poh Gek Chua, Suay Hong Gan, Cynthia B.E. Chee, Sze Ling Chan, Yee Tang Wang, Marie Loh, Liam R. Brunham, Shengnan Jin, Folefac Aminkeng
Publikováno v:
PLoS ONE
PLoS ONE, Vol 12, Iss 10, p e0186200 (2017)
PLoS ONE, Vol 12, Iss 10, p e0186200 (2017)
BACKGROUND AND AIMS Isoniazid (INH) is part of the first-line-therapy for tuberculosis (TB) but can cause drug-induced liver injury (DILI). Several candidate single nucleotide polymorphisms (SNPs) have been previously identified but the clinical util
Publikováno v:
BMJ case reports. 2015
Drug-resistant tuberculosis (TB) continues to pose a threat to global control of TB: 3.5% of new and 20.5% of previously treated TB cases were estimated to have multidrug-resistant (MDR)-TB in 2013. Approximately 9% of patients with MDR-TB had extens
INTRODUCTION The 'DOT & Shop' scheme is sponsored by SATA CommHealth, a local non-governmental organisation. It was launched in July 2009, in collaboration with Singapore's Tuberculosis Control Unit (TBCU). Under this scheme, grocery vouchers are dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f30b09e5f23ba79c51720eeeb5f42cf
https://europepmc.org/articles/PMC4447929/
https://europepmc.org/articles/PMC4447929/